Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | PTPRB | P23467 | 1/20 | 0.31 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17923978 | 0.90 | CA14 (0.43) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL17923992 | 0.83 | CA14 (0.38) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL17923883 | 0.83 | ALDH1A1 (0.33) | CA12MEN1KMT2ACA9 | |
| SCHEMBL28855147 | 0.82 | CA14 (0.43) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL17923990 | 0.82 | CA14 (0.43) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL18127578 | 0.81 | CA14 (0.39) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL18127550 | 0.81 | CA14 (0.39) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL25476912 | 0.80 | CA14 (0.36) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL17923901 | 0.80 | CA14 (0.36) | CA14CA12MEN1KMT2ACA7 | |
| SCHEMBL17923926 | 0.80 | CA14 (0.36) | CA14CA12MEN1KMT2ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12494506-B2 | Nonaqueous electrolytic solution and energy device including the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-12-09 | — | — | US | disclosed |
| EP-3780227-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY DEVICE INCLUDING THE SAME | MITSUBISHI CHEM CORP (JP) | 2024-07-24 | — | — | EP | disclosed |
| EP-3780225-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ELECTRICAL STORAGE DEVICE INCLUDING THE SAME | MITSUBISHI CHEM CORP (JP) | 2024-07-24 | — | — | EP | disclosed |
| CN-111801833-B | Nonaqueous electrolyte and energy device using same | 三菱化学株式会社 | 2024-07-16 | — | — | CN | disclosed |
| US-12009482-B2 | Nonaqueous electrolytic solution and electrical storage device including the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-06-11 | — | — | US | disclosed |
| CN-111788733-B | Nonaqueous electrolyte and power storage device using same | 三菱化学株式会社 | 2024-02-02 | — | — | CN | disclosed |
| EP-4080533-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE | Mitsubishi Chemical Corporation (JP) | 2022-10-26 | — | — | EP | disclosed |
| US-20220328878-A1 | Non-Aqueous Electrolyte Solution and Energy Device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-10-13 | — | — | US | disclosed |
| CN-114846669-A | Nonaqueous electrolyte solution and energy device | 三菱化学株式会社 | 2022-08-02 | — | — | CN | disclosed |
| EP-3780227-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | Mitsubishi Chemical Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20180034105-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3273520-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE SECONDARY CELL IN WHICH SAME IS USED | Mitsubishi Chemical Corporation (JP) | 2018-01-24 | — | — | EP | disclosed |
| EP-3252861-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME | Mitsubishi Chemical Corporation (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-3098893-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | MITSUBISHI CHEM CORP (JP) | 2017-11-29 | — | — | EP | disclosed |
| US-20170324116-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| EP-3098893-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING SAME | Mitsubishi Chemical Corporation (JP) | 2016-11-30 | — | — | EP | disclosed |
| US-20160322669-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| US-9461334-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| EP-3051618-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | Mitsubishi Chemical Corporation (JP) | 2016-08-03 | — | — | EP | disclosed |
| US-20160211553-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170324116-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME | KCNN2, KCNE1, KCNN1 | CA14 76/4885CA12 88/4885MEN1 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.